| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 05/29/2007 | US7223791 Function regulator for retinoid relative receptor |
| 05/29/2007 | US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 05/29/2007 | US7223774 Benzamide 2-hydroxy-3-diaminoalkanes |
| 05/23/2007 | EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220865 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal |
| 05/22/2007 | US7220768 Prevention reproduction of herpes virus |
| 05/22/2007 | US7220745 Viricides; therapy for hepatitis virus infections |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
| 05/18/2007 | WO2007055928A1 5-membered ring metanicotine analogs |
| 05/17/2007 | US20070112036 Opioid receptor antagonists |
| 05/17/2007 | US20070112035 Substituted oxyarenes |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111971 Novel compounds |
| 05/16/2007 | EP1784388A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 05/16/2007 | EP1684752B1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 05/16/2007 | EP1465638B1 Phosphate transport inhibitors |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/15/2007 | US7217740 Diarylsulfones as 5-HT2A antagonists |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217727 Phospholipase inhibitors |
| 05/10/2007 | WO2007053436A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007051847A1 Tricyclo substituted amides as glucokinase modulators |
| 05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | CA2626504A1 Tricyclo substituted amides as glucokinase modulators |
| 05/09/2007 | EP1781674A1 Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer |
| 05/09/2007 | EP1781595A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 05/09/2007 | EP1781285A2 Mitotic kinesin inhibitors |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/03/2007 | WO2007048557A1 Protease inhibitors |
| 05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 05/02/2007 | EP1778628A1 Organic compounds |
| 05/02/2007 | EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/01/2007 | CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents |
| 05/01/2007 | CA2162630C Sulfonamides |
| 04/26/2007 | WO2007047305A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007046411A1 Method for stabilization of isoxazole compound |
| 04/26/2007 | WO2007027230A3 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 04/26/2007 | US20070093539 N-hydroxy-4-(3-pheyl-5-methyl-isoxazole-4-yl)-benzenesulfonate solvates |
| 04/26/2007 | US20070093483 Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088067 Novel amidine compounds for treating microbial infections |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1425276B1 Heterocyclic carboxamides and their use as fungicides |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | CN1950334A Ortho substituted aryl or heteroaryl amide compounds |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | US7205405 Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/12/2007 | WO2007016209A3 Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process |
| 04/12/2007 | WO2007002214A3 Acyl guanidines as beta-secretase inhibitors |
| 04/12/2007 | US20070082903 Remedy for rheumatoid arthritis |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/11/2007 | EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/11/2007 | CN1309711C 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 04/10/2007 | US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein |
| 04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
| 04/05/2007 | WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | WO2007006409A3 Herbicide-safener combination |
| 04/05/2007 | WO2007002172A3 Hiv-1 protease inhibitors |
| 04/05/2007 | WO2006055184A3 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 04/05/2007 | US20070078124 1-Aza-2-oxa-dibenzo(e,h)azulenes and their use for the treatment of central nervous system diseases and disorders |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/04/2007 | EP1768966A1 Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 04/04/2007 | CN1942428A CETP inhibitors |
| 04/04/2007 | CN1308315C Method for preparing benzenesulfonyl compounds |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308302C Taxol enhancer compounds |
| 04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
| 04/03/2007 | US7199248 Process |
| 03/29/2007 | WO2007034035A1 Sulphonamide derivatives |
| 03/29/2007 | US20070072921 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide |
| 03/29/2007 | CA2622086A1 Sulphonamide derivatives |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | CA2251820C Substituted benzylamines and their use for the treatment of depression |
| 03/27/2007 | CA2169145C Substituted benzisoxazole and benzisothiazole herbicidal agents |
| 03/22/2007 | WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| 03/22/2007 | WO2007032441A1 Method for sulfonating 1,2-benzisoxazole-3-acetic acid |
| 03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
| 03/22/2007 | US20070066830 Method for sulfonation of 1,2-benzisoxazole-3-acetic acid |
| 03/22/2007 | US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders |
| 03/22/2007 | US20070066617 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly |
| 03/22/2007 | CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| 03/21/2007 | CN1934096A One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide |
| 03/21/2007 | CN1934066A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 03/21/2007 | CN1933826A Novel pharmaceutical compositions comprising agonists of the thyroid receptor |
| 03/21/2007 | CN1305858C Substituted azole compounds and their preparation and application |
| 03/20/2007 | CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production |
| 03/15/2007 | WO2007030582A2 Acyclic ikur inhibitors |
| 03/15/2007 | WO2007002220A3 Aminoacetamide acyl guanidines as beta-secretase inhibitors |
| 03/15/2007 | WO2006023440A3 Mitotic kinesin inhibitors |